The Glioma-BioDP tool’s functionality and potential clinical relevance is demonstrated through the analyses of the following genes: PTEN, NES, TERT, MGMT and EGFR. The clinical relevance of PTEN in gliomas is explained in the previous section. The gene discussed is MGMT; the disease is central nervous system cancer.